Columbus-based Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has launched a program dedicated to patients with early-onset and young adult cancers.
The BRIDGE Program — which stands for Building Research Innovation and Care Delivery for Groups with Early Onset Cancers — aims to serve patients ages 18-50 by aligning clinical services such as fertility counseling and genomic testing early in the care process, according to a Dec. 15 news release from the cancer center.
The program is expected to receive a $20 million investment over five years to support new clinical services, staffing and research. That includes a competitive intramural grant program, funded by nonprofit organization Pelotonia, to support cross-disease research in tumor biology, genetics and outcomes for early-onset cancers.
W. Kimryn Rathmell, MD, who was appointed CEO of OSUCCC-James in April, is leading the initiative as part of her administration. Dr. Rathmell previously led similar efforts at the National Cancer Institute and has called early-onset cancer a growing clinical and scientific priority.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
